A citation-based method for searching scientific literature

Charles L Raison, Lucile Capuron, Andrew H Miller. Trends Immunol 2006
Times Cited: 1609







List of co-cited articles
698 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


From inflammation to sickness and depression: when the immune system subjugates the brain.
Robert Dantzer, Jason C O'Connor, Gregory G Freund, Rodney W Johnson, Keith W Kelley. Nat Rev Neurosci 2008
29

A meta-analysis of cytokines in major depression.
Yekta Dowlati, Nathan Herrmann, Walter Swardfager, Helena Liu, Lauren Sham, Elyse K Reim, Krista L Lanctôt. Biol Psychiatry 2010
24

Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression.
Andrew H Miller, Vladimir Maletic, Charles L Raison. Biol Psychiatry 2009
23


Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder.
Rita Haapakoski, Julia Mathieu, Klaus P Ebmeier, Harri Alenius, Mika Kivimäki. Brain Behav Immun 2015
409
13


Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
M Bryant Howren, Donald M Lamkin, Jerry Suls. Psychosom Med 2009
10

Inflammation and clinical response to treatment in depression: A meta-analysis.
R Strawbridge, D Arnone, A Danese, A Papadopoulos, A Herane Vives, A J Cleare. Eur Neuropsychopharmacol 2015
253
9

A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers.
Charles L Raison, Robin E Rutherford, Bobbi J Woolwine, Chen Shuo, Pamela Schettler, Daniel F Drake, Ebrahim Haroon, Andrew H Miller. JAMA Psychiatry 2013
779
9


Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies.
C A Köhler, T H Freitas, M Maes, N Q de Andrade, C S Liu, B S Fernandes, B Stubbs, M Solmi, N Veronese, N Herrmann,[...]. Acta Psychiatr Scand 2017
376
8

CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies.
Vyara Valkanova, Klaus P Ebmeier, Charlotte L Allan. J Affect Disord 2013
432
8

Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host's metabolism.
P Zheng, B Zeng, C Zhou, M Liu, Z Fang, X Xu, L Zeng, J Chen, S Fan, X Du,[...]. Mol Psychiatry 2016
572
7

Altered fecal microbiota composition in patients with major depressive disorder.
Haiyin Jiang, Zongxin Ling, Yonghua Zhang, Hongjin Mao, Zhanping Ma, Yan Yin, Weihong Wang, Wenxin Tang, Zhonglin Tan, Jianfei Shi,[...]. Brain Behav Immun 2015
663
7

Evidence for an immune response in major depression: a review and hypothesis.
M Maes. Prog Neuropsychopharmacol Biol Psychiatry 1995
598
7

Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials.
Ole Köhler, Michael E Benros, Merete Nordentoft, Michael E Farkouh, Rupa L Iyengar, Ole Mors, Jesper Krogh. JAMA Psychiatry 2014
396
7

The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis.
Jonas Hannestad, Nicole DellaGioia, Michael Bloch. Neuropsychopharmacology 2011
500
7

Immune system to brain signaling: neuropsychopharmacological implications.
Lucile Capuron, Andrew H Miller. Pharmacol Ther 2011
544
6

Transferring the blues: Depression-associated gut microbiota induces neurobehavioural changes in the rat.
John R Kelly, Yuliya Borre, Ciaran O' Brien, Elaine Patterson, Sahar El Aidy, Jennifer Deane, Paul J Kennedy, Sasja Beers, Karen Scott, Gerard Moloney,[...]. J Psychiatr Res 2016
455
6

The macrophage theory of depression.
R S Smith. Med Hypotheses 1991
512
6

Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions.
Lucile Capuron, Jane F Gumnick, Dominique L Musselman, David H Lawson, Andrea Reemsnyder, Charles B Nemeroff, Andrew H Miller. Neuropsychopharmacology 2002
446
6

Depressive disorders and immunity: 20 years of progress and discovery.
Michael R Irwin, Andrew H Miller. Brain Behav Immun 2007
379
6

Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study.
D Gimeno, M Kivimäki, E J Brunner, M Elovainio, R De Vogli, A Steptoe, M Kumari, G D O Lowe, A Rumley, M G Marmot,[...]. Psychol Med 2009
314
6

CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression.
C L Raison, R Dantzer, K W Kelley, M A Lawson, B J Woolwine, G Vogt, J R Spivey, K Saito, A H Miller. Mol Psychiatry 2010
370
6

Is depression associated with increased oxidative stress? A systematic review and meta-analysis.
Catherine N Black, Mariska Bot, Peter G Scheffer, Pim Cuijpers, Brenda W J H Penninx. Psychoneuroendocrinology 2015
256
6


The relationship of depression and stressors to immunological assays: a meta-analytic review.
E P Zorrilla, L Luborsky, J R McKay, R Rosenthal, A Houldin, A Tax, R McCorkle, D A Seligman, K Schmidt. Brain Behav Immun 2001
515
6

Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve.
Javier A Bravo, Paul Forsythe, Marianne V Chew, Emily Escaravage, Hélène M Savignac, Timothy G Dinan, John Bienenstock, John F Cryan. Proc Natl Acad Sci U S A 2011
5

Correlation between the human fecal microbiota and depression.
A Naseribafrouei, K Hestad, E Avershina, M Sekelja, A Linløkken, R Wilson, K Rudi. Neurogastroenterol Motil 2014
395
5

Possible association of Bifidobacterium and Lactobacillus in the gut microbiota of patients with major depressive disorder.
Emiko Aizawa, Hirokazu Tsuji, Takashi Asahara, Takuya Takahashi, Toshiya Teraishi, Sumiko Yoshida, Miho Ota, Norie Koga, Kotaro Hattori, Hiroshi Kunugi. J Affect Disord 2016
163
5

So depression is an inflammatory disease, but where does the inflammation come from?
Michael Berk, Lana J Williams, Felice N Jacka, Adrienne O'Neil, Julie A Pasco, Steven Moylan, Nicholas B Allen, Amanda L Stuart, Amie C Hayley, Michelle L Byrne,[...]. BMC Med 2013
514
5

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.
A John Rush, Madhukar H Trivedi, Stephen R Wisniewski, Andrew A Nierenberg, Jonathan W Stewart, Diane Warden, George Niederehe, Michael E Thase, Philip W Lavori, Barry D Lebowitz,[...]. Am J Psychiatry 2006
5

Antidepressant treatment resistance is associated with increased inflammatory markers in patients with major depressive disorder.
Ebrahim Haroon, Alexander W Daguanno, Bobbi J Woolwine, David R Goldsmith, Wendy M Baer, Evanthia C Wommack, Jennifer C Felger, Andrew H Miller. Psychoneuroendocrinology 2018
74
6

Integrating neuroimmune systems in the neurobiology of depression.
Eric S Wohleb, Tina Franklin, Masaaki Iwata, Ronald S Duman. Nat Rev Neurosci 2016
217
5

Peripheral Alterations in Cytokine and Chemokine Levels After Antidepressant Drug Treatment for Major Depressive Disorder: Systematic Review and Meta-Analysis.
Cristiano A Köhler, Thiago H Freitas, Brendon Stubbs, Michael Maes, Marco Solmi, Nicola Veronese, Nayanna Q de Andrade, Gerwyn Morris, Brisa S Fernandes, André R Brunoni,[...]. Mol Neurobiol 2018
147
5

Depression as a microglial disease.
Raz Yirmiya, Neta Rimmerman, Ronen Reshef. Trends Neurosci 2015
311
5

Cerebrospinal cytokine levels in patients with acute depression.
J Levine, Y Barak, K N Chengappa, A Rapoport, M Rebey, V Barak. Neuropsychobiology 1999
206
5


Pathogenesis of depression: Insights from human and rodent studies.
C Ménard, G E Hodes, S J Russo. Neuroscience 2016
144
5

Inflammation in Depression and the Potential for Anti-Inflammatory Treatment.
Ole Kohler, Jesper Krogh, Ole Mors, Michael Eriksen Benros. Curr Neuropharmacol 2016
140
5

Elevated C-reactive protein levels, psychological distress, and depression in 73, 131 individuals.
Marie Kim Wium-Andersen, David Dynnes Ørsted, Sune Fallgaard Nielsen, Børge Grønne Nordestgaard. JAMA Psychiatry 2013
223
5


Cytokine targets in the brain: impact on neurotransmitters and neurocircuits.
Andrew H Miller, Ebrahim Haroon, Charles L Raison, Jennifer C Felger. Depress Anxiety 2013
337
5

Efficacy of anti-inflammatory treatment on major depressive disorder or depressive symptoms: meta-analysis of clinical trials.
O Köhler-Forsberg, C N Lydholm, C Hjorthøj, M Nordentoft, O Mors, M E Benros. Acta Psychiatr Scand 2019
64
7


The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression.
Michael Maes, Raz Yirmyia, Jens Noraberg, Stefan Brene, Joe Hibbeln, Giulia Perini, Marta Kubera, Petr Bob, Bernard Lerer, Mario Maj. Metab Brain Dis 2009
487
5

The role of pro-inflammatory cytokines in neuroinflammation, neurogenesis and the neuroendocrine system in major depression.
Yong-Ku Kim, Kyoung-Sae Na, Aye-Mu Myint, Brian E Leonard. Prog Neuropsychopharmacol Biol Psychiatry 2016
196
5

Major depressive disorder.
Christian Otte, Stefan M Gold, Brenda W Penninx, Carmine M Pariante, Amit Etkin, Maurizio Fava, David C Mohr, Alan F Schatzberg. Nat Rev Dis Primers 2016
366
5

Depression.
Gin S Malhi, J John Mann. Lancet 2018
346
5

The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine.
N Müller, M J Schwarz, S Dehning, A Douhe, A Cerovecki, B Goldstein-Müller, I Spellmann, G Hetzel, K Maino, N Kleindienst,[...]. Mol Psychiatry 2006
447
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.